Marc Goodman
Stock Analyst at Leerink Partners
(4.86)
# 368
Out of 5,051 analysts
819
Total ratings
55%
Success rate
18.5%
Average return
Main Sectors:
Stocks Rated by Marc Goodman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NGEN NervGen Pharma | Reiterated: Buy | $10 | $1.73 | +478.03% | 2 | Oct 1, 2026 | |
| EOLS Evolus | Reiterated: Buy | n/a | $7.75 | - | 43 | Sep 16, 2026 | |
| RAPP Rapport Therapeutics | Initiated Coverage: Buy | $52 | $30.15 | +72.47% | 1 | Jun 24, 2026 | |
| STOK Stoke Therapeutics | Reiterated: Buy | n/a | $24.15 | - | 11 | Jun 2, 2026 | |
| SPTX Seaport Therapeutics | Initiated Coverage: Buy | $35 | $17.15 | +104.08% | 1 | May 27, 2026 | |
| ACIU AC Immune | Reiterated: Buy | n/a | $2.45 | - | 38 | Apr 7, 2026 | |
| ALKS Alkermes | Reiterated: Hold | n/a | $40.26 | - | 45 | Mar 31, 2026 | |
| SGP SpyGlass Pharma | Initiated Coverage: Buy | $42 | $24.86 | +68.95% | 1 | Mar 3, 2026 | |
| MANE Veradermics | Initiated Coverage: Buy | $75 | $122.40 | -38.73% | 1 | Mar 2, 2026 | |
| NMRA Neumora Therapeutics | Initiated Coverage: Buy | $8 | $0.4373 | +1,729.41% | 1 | Jan 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $15 | $11.81 | +27.01% | 26 | Dec 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $8.60 | +248.84% | 1 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $2.41 | +107.47% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $158.59 | -46.40% | 13 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $7.88 | n/a | 13 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $30 | $19.41 | n/a | 46 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $20 | $27.48 | n/a | 34 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $166.00 | n/a | 52 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $229.41 | n/a | 58 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $215 | $216.75 | n/a | 54 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $35.81 | n/a | 31 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $35.93 | n/a | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $141.37 | n/a | 48 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $2.26 | n/a | 4 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $18.95 | n/a | 16 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.9058 | n/a | 40 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $35.20 | n/a | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $3.61 | n/a | 11 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.51 | n/a | 33 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1 | $0.023 | n/a | 9 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $263.73 | n/a | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $10.83 | n/a | 17 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $1.40 | n/a | 1 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $70 | $1.21 | n/a | 12 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $60.48 | n/a | 10 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.97 | n/a | 2 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $53.52 | n/a | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $171.33 | n/a | 1 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $46.84 | n/a | 1 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $301.86 | n/a | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $507.00 | n/a | 2 | Mar 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $473 | $762.81 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $72 → $57 | $57.58 | n/a | 17 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $54 | $17.54 | n/a | 8 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $28.40 | n/a | 15 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 | $145.45 | n/a | 16 | Oct 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $95 | $281.12 | n/a | 14 | Oct 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $98 | $15.45 | n/a | 8 | Oct 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $85 | $1,182.62 | n/a | 12 | Jul 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $28 → $12 | $20.03 | n/a | 8 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 | $150.43 | n/a | 3 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 | $3.76 | n/a | 3 | Jun 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $8.64 | n/a | 24 | Mar 21, 2016 |
NervGen Pharma
Oct 1, 2026
Reiterated: Buy
Price Target: $10
Current: $1.73
Upside: +478.03%
Evolus
Sep 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.75
Upside: -
Rapport Therapeutics
Jun 24, 2026
Initiated Coverage: Buy
Price Target: $52
Current: $30.15
Upside: +72.47%
Stoke Therapeutics
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $24.15
Upside: -
Seaport Therapeutics
May 27, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $17.15
Upside: +104.08%
AC Immune
Apr 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.45
Upside: -
Alkermes
Mar 31, 2026
Reiterated: Hold
Price Target: n/a
Current: $40.26
Upside: -
SpyGlass Pharma
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $24.86
Upside: +68.95%
Veradermics
Mar 2, 2026
Initiated Coverage: Buy
Price Target: $75
Current: $122.40
Upside: -38.73%
Neumora Therapeutics
Jan 11, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $0.4373
Upside: +1,729.41%
Dec 25, 2025
Reiterated: Buy
Price Target: $50 → $15
Current: $11.81
Upside: +27.01%
Nov 21, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $8.60
Upside: +248.84%
Nov 17, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $2.41
Upside: +107.47%
Oct 15, 2025
Reiterated: Buy
Price Target: $85
Current: $158.59
Upside: -46.40%
Oct 9, 2025
Reiterated: Buy
Price Target: $50
Current: $7.88
Upside: n/a
Oct 7, 2025
Reiterated: Buy
Price Target: $32 → $30
Current: $19.41
Upside: n/a
Oct 7, 2025
Reiterated: Buy
Price Target: $10 → $20
Current: $27.48
Upside: n/a
Oct 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $166.00
Upside: n/a
Oct 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $229.41
Upside: n/a
Oct 7, 2025
Reiterated: Buy
Price Target: $215
Current: $216.75
Upside: n/a
Oct 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $35.81
Upside: n/a
Oct 6, 2025
Initiated Coverage: Buy
Price Target: $34
Current: $35.93
Upside: n/a
Sep 23, 2025
Reiterated: Buy
Price Target: n/a
Current: $141.37
Upside: n/a
Sep 16, 2025
Reiterated: Buy
Price Target: $20
Current: $2.26
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $40
Current: $18.95
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $10
Current: $0.9058
Upside: n/a
Aug 1, 2025
Reiterated: Buy
Price Target: $20
Current: $35.20
Upside: n/a
Aug 1, 2025
Reiterated: Buy
Price Target: $36
Current: $3.61
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.51
Upside: n/a
Mar 26, 2025
Downgraded: Hold
Price Target: $1
Current: $0.023
Upside: n/a
Jan 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $263.73
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $4
Current: $10.83
Upside: n/a
Jan 24, 2023
Initiated Coverage: Buy
Price Target: $24
Current: $1.40
Upside: n/a
Jul 11, 2022
Reiterated: Hold
Price Target: $70
Current: $1.21
Upside: n/a
Jul 11, 2022
Reiterated: Hold
Price Target: $20
Current: $60.48
Upside: n/a
Jun 27, 2022
Reiterated: Hold
Price Target: n/a
Current: $5.97
Upside: n/a
May 3, 2022
Reiterated: Buy
Price Target: n/a
Current: $53.52
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: $25
Current: $171.33
Upside: n/a
May 4, 2021
Reiterated: Buy
Price Target: n/a
Current: $46.84
Upside: n/a
Apr 5, 2021
Reiterated: Buy
Price Target: $31
Current: $301.86
Upside: n/a
Mar 19, 2019
Downgraded: Hold
Price Target: n/a
Current: $507.00
Upside: n/a
Nov 12, 2018
Initiated Coverage: Buy
Price Target: $473
Current: $762.81
Upside: n/a
May 21, 2018
Downgraded: Hold
Price Target: $72 → $57
Current: $57.58
Upside: n/a
Mar 1, 2018
Reiterated: Buy
Price Target: $46 → $54
Current: $17.54
Upside: n/a
Jan 31, 2018
Reiterated: Buy
Price Target: $42
Current: $28.40
Upside: n/a
Oct 30, 2017
Reiterated: Buy
Price Target: $67
Current: $145.45
Upside: n/a
Oct 13, 2017
Reiterated: Hold
Price Target: $95
Current: $281.12
Upside: n/a
Oct 5, 2017
Reiterated: Buy
Price Target: $110 → $98
Current: $15.45
Upside: n/a
Jul 26, 2017
Reiterated: Hold
Price Target: $85
Current: $1,182.62
Upside: n/a
Nov 10, 2016
Reiterated: Sell
Price Target: $28 → $12
Current: $20.03
Upside: n/a
Nov 2, 2016
Reiterated: Buy
Price Target: $118
Current: $150.43
Upside: n/a
Jun 14, 2016
Reiterated: Sell
Price Target: $8
Current: $3.76
Upside: n/a
Mar 21, 2016
Rated: Buy
Price Target: n/a
Current: $8.64
Upside: n/a